DOI: 10.36871/vet.zoo.bio.202109005
UDC 619: 615.1: 615.284
Authors
A. K. Klyueva
Postgraduate student of the Department of Physiology, Pharmacology
and Toxicology by A. N. Golikov and I. E. Mozgov,
Moscow State Academy of Veterinary Medicine
and Biotechnology – MVA by K. I. Skryabin,
Moscow, Russian Federation
A. A. Deltsov
Doctor of Veterinary Sciences, Professor, Moscow
State Academy of Veterinary Medicine and
Biotechnology – MVA by K.I. Skryabin,
Moscow, Russian Federation
K. O. Belova
Student of Faculty of the Veterinary Medicine,
Moscow State Academy of Veterinary Medicine
and Biotechnology – MVA by K. I. Skryabin,
Moscow, Russian Federation
Abstract
This paper presents an analysis of the range of veterinary medicines registered in the territory of
the Russian Federation and used for the prevention and treatment of helminthiasis.
The Russian Federation is a leader in the development and production of anthelmintic medicines
registered on its territory.
Antiparasitic medicines used for the prevention and treatment of helminthiasis are divided according
to the spectrum of action depending on the class of helminths. It was revealed that the majority of
medicines (89 medicines – 58,17%) have a wide spectrum of action. Of these, 62 medicines (40,52% of the
total amount of anthelmintic medicines) are intended for the treatment of nematodes and cestodoses.
When distributing anthelmintic medicines among target animals, it was found that 75 medicines
(49,02%) are intended for the treatment of productive animals, and 78 medicines (50,98%) are
intended for the treatment of unproductive animals.
When assessing the dynamics of state registration of anthelmintic medicines for veterinary use,
it can be noted that over the past 4 years there has been a tendency towards an increase in the
average annual registration.
Keywords
medicines, veterinary pharmacy, pharmaceutical market, anthelmintic medicines.
